Cargando…

Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings

BACKGROUND & AIMS: Abdominal symptoms (AS) are a hallmark of the multiorgan-disease cystic fibrosis (CF). However, the abdominal involvement in CF is insufficiently understood and, compared to the pulmonary manifestation, still receives little scientific attention. Aims were to assess and quanti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabori, Harold, Arnold, Christin, Jaudszus, Anke, Mentzel, Hans-Joachim, Renz, Diane M., Reinsch, Steffen, Lorenz, Michael, Michl, Ruth, Gerber, Andrea, Lehmann, Thomas, Mainz, Jochen G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417419/ https://www.ncbi.nlm.nih.gov/pubmed/28472055 http://dx.doi.org/10.1371/journal.pone.0174463

Ejemplares similares

Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients
por: Tabori, Harold, et al.
Publicado: (2017)

Pseudomonas aeruginosa colonization in the upper and lower airways of a child with cystic fibrosis: a father’s meticulous approach to successful eradication
por: Mainz, Jochen Georg, et al.
Publicado: (2019)

Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with CFTR Mutations Causing Pancreatic Insufficiency
por: Tabori, Harold, et al.
Publicado: (2022)

Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts
por: Mainz, Jochen G., et al.
Publicado: (2015)

Reduced Nasal Nitric Oxide Production in Cystic Fibrosis Patients with Elevated Systemic Inflammation Markers
por: Michl, Ruth K., et al.
Publicado: (2013)

One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis
por: Jaudszus, Anke, et al.
Publicado: (2022)

Effects of a dietary intervention with conjugated linoleic acid on immunological and metabolic parameters in children and adolescents with allergic asthma – a placebo-controlled pilot trial
por: Jaudszus, Anke, et al.
Publicado: (2016)

Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid
por: Mainz, Jochen G., et al.
Publicado: (2021)

Preliminary results of abdominal simultaneous multi-slice accelerated diffusion-weighted imaging with motion-correction in patients with cystic fibrosis and impaired compliance
por: Glutig, Katja, et al.
Publicado: (2022)

EPS4.7 Cytokine dynamics in upper airway epithelial lining fluid of CF patients in relation to the status of colonization with Pseudomonas aeruginosa
por: Jaudszus, A., et al.
Publicado: (2017)

Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment
por: Hentschel, Julia, et al.
Publicado: (2014)

Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study
por: Mainz, Jochen G, et al.
Publicado: (2014)

Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other Forms
por: Cuenoud, Bernard, et al.
Publicado: (2020)

The Cystic Fibrosis Upper and Lower Airway Metagenome
por: Pienkowska, Katarzyna, et al.
Publicado: (2023)

Ultrashort echo time MRI of the lung in children and adolescents: comparison with non-enhanced computed tomography and standard post-contrast T1w MRI sequences
por: Renz, Diane M., et al.
Publicado: (2021)

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2022)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2023)

Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
por: Müller, Ulrike, et al.
Publicado: (2015)

Would it have happened without Christmas? Thoracic emphysema and allergic bronchopulmonary aspergillosis in a juvenile cystic fibrosis patient with the G551D mutation receiving ivacaftor
por: Mainz, Jochen G., et al.
Publicado: (2021)

Searching for health beneficial n-3 and n-6 fatty acids in plant seeds
por: Kuhnt, Katrin, et al.
Publicado: (2012)

Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage
por: Erdmann, Nina, et al.
Publicado: (2022)

Abdominal Cystic Mass for Evaluation
por: Kannan, Kanakaraj, et al.
Publicado: (2020)

Cystic echinococcosis in the abdominal wall
por: Ronzoni, Niccolò, et al.
Publicado: (2023)

Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies()
por: Stefano, Marina A., et al.
Publicado: (2020)

Non-Invasive Evaluation of Cystic Fibrosis Related Liver Disease in Adults with ARFI, Transient Elastography and Different Fibrosis Scores
por: Karlas, Thomas, et al.
Publicado: (2012)

Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-Helper Cells
por: Jaudszus, Anke, et al.
Publicado: (2014)

Anthocyanin-Rich Juice Lowers Serum Cholesterol, Leptin, and Resistin and Improves Plasma Fatty Acid Composition in Fischer Rats
por: Graf, Daniela, et al.
Publicado: (2013)

Abdominal Cystic Lymphangioma Mimicking Appendicitis
por: Wake, Sarah, et al.
Publicado: (2013)

Cystic intra-abdominal masses in children
por: Ferrero, Luisa, et al.
Publicado: (2017)

Giant intra-abdominal cystic lymphangioma
por: Altintoprak, Fatih, et al.
Publicado: (2019)

Imaging the Abdominal Manifestations of Cystic Fibrosis
por: Gillespie, C. D., et al.
Publicado: (2017)

Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy
por: Eschenhagen, Patience N., et al.
Publicado: (2023)

Fatty acid distribution of cord and maternal blood in human pregnancy: special focus on individual trans fatty acids and conjugated linoleic acids
por: Enke, Uta, et al.
Publicado: (2011)

Bronchial artery diameter in massive hemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2022)

Künstliche Intelligenz bei Bildauswertung und Diagnosefindung: Was bringt das in der Kinder- und Jugendradiologie?
por: Mentzel, Hans-Joachim
Publicado: (2021)

Cystic Lymphangioma as a Cause of Massive Abdominal Hemorrhage
por: Llapur, E. Consuegra, et al.
Publicado: (2011)

The role of laboratory investigations in evaluating abdominal tuberculosis
por: Rana, Sherwani, et al.
Publicado: (2015)

Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study
por: Bell, Scott C., et al.
Publicado: (2019)

Coil embolisation for massive haemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2021)

Extreme Cystic Dilatation of the Fallopian Tubes; Abdominal Section; Recovery
por: Chapman, J. Milne
Publicado: (1884)

Cannot write session to /tmp/vufind_sessions/sess_82epqi1cg138ai68ntuceccht8